Urothelial Carcinoma Bladder

specific

A carcinoma that arises from the urothelial lining of the bladder. It is the most common morphologic type of urinary bladder carcinoma. It usually affects males in their sixth and seventh decades of life. Hematuria is the most common symptom at presentation. Pathologic stage is the strongest predictor of survival.

Centers

Active Trials

—

Cancer Funding

Top Centers for Urothelial Carcinoma Bladder(33)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX High-Volume Research Center	High-Volume Research Center	4	—	73.3
2	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program	Active Research Program	1	—	67.9
3	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program	Active Research Program	1	—	67.9
4	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	67.9
5	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program	Active Research Program	1	—	67.9
6	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical Active Research Program	Active Research Program	1	—	67.9
7	Cleveland Clinic Cancer CenterCleveland, OH Active Research Program	Active Research Program	1	—	67.9
8	Loma Linda University Cancer CenterLoma Linda, CA Active Research Program	Active Research Program	1	—	67.9
9	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive		—	—	46.1
10	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive		—	—	46.1
11	UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive		—	—	46.1
12	Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive		—	—	46.1
13	Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive		—	—	46.1
14	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive		—	—	46.1
15	Duke Cancer InstituteDurham, NC NCI Comprehensive		—	—	46.1
16	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive		—	—	46.1
17	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive		—	—	46.1
18	University of Colorado Cancer CenterAurora, CO NCI Comprehensive		—	—	46.1
19	Moffitt Cancer CenterTampa, FL NCI Comprehensive		—	—	46.1
20	UF Health Cancer InstituteGainesville, FL NCI Clinical		—	—	46.1
21	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive		—	—	46.1
22	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical		—	—	46.1
23	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive		—	—	46.1
24	University of Illinois Cancer CenterChicago, IL		—	—	46.1
25	Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive		—	—	46.1
26	Boston University Cancer CenterBoston, MA		—	—	46.1
27	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive		—	—	46.1
28	Stony Brook Cancer CenterStony Brook, NY		—	—	46.1
29	Penn State Cancer InstituteHershey, PA		—	—	46.1
30	Legorreta Cancer Center at Brown UniversityProvidence, RI		—	—	46.1
31	Northwell Health Cancer InstituteNew York, NY		—	—	46.1
32	Louisiana Cancer Research CenterNew Orleans, LA		—	—	46.1
33	Tampa General Hospital Cancer InstituteTampa, FL		—	—	46.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →